Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Debt Ratio (2022 - 2025)

Cue Biopharma (CUE) has disclosed Debt Ratio for 4 consecutive years, with 0.05 as the latest value for Q3 2025.

  • Quarterly Debt Ratio fell 55.89% to 0.05 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.05 through Sep 2025, down 55.89% year-over-year, with the annual reading at 0.13 for FY2024, 1.43% up from the prior year.
  • Debt Ratio hit 0.05 in Q3 2025 for Cue Biopharma, down from 0.06 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.15 in Q1 2025 to a low of 0.05 in Q3 2025.
  • Historically, Debt Ratio has averaged 0.12 across 4 years, with a median of 0.13 in 2022.
  • Biggest five-year swings in Debt Ratio: grew 21.16% in 2023 and later plummeted 56.89% in 2025.
  • Year by year, Debt Ratio stood at 0.11 in 2022, then grew by 21.16% to 0.13 in 2023, then rose by 1.43% to 0.13 in 2024, then plummeted by 61.31% to 0.05 in 2025.
  • Business Quant data shows Debt Ratio for CUE at 0.05 in Q3 2025, 0.06 in Q2 2025, and 0.15 in Q1 2025.